A replication study examining novel common single nucleotide polymorphisms identified through a prostate cancer genome-wide association study in a Japanese population

American Journal of Epidemiology

Volumn 174, Issue 12, 2011, Pages 1391-1395

  Batra, Jyotsna ^a   Lose, Felicity ^a   Chambers, Suzanne ^a   Gardiner, Robert A ^a   Aitken, Joanne ^a   Yaxley, John ^a   Clements, Judith A ^a   Spurdle, Amanda B ^a  

^a NONE

Author keywords

Ethnic groups; Genome wide association study; Linkage disequilibrium; Polymorphism, single nucleotide; Prostatic neoplasms

Indexed keywords

TELOMERASE REVERSE TRANSCRIPTASE;

CANCER; COHORT ANALYSIS; ETHNIC GROUP; ETHNICITY; EXPERIMENTAL STUDY; GENE EXPRESSION; GENOME; HEALTH IMPACT; HEALTH RISK; POLYMORPHISM; PREDICTION; PROTEIN; PUBLIC HEALTH;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; INTRON; JAPANESE; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; REPLICATION STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; TIGHT JUNCTION;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

JAPAN;

EID: 83755186533     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwr271     Document Type: Article

References (21)

1. Gudmundsson J, Sulem P, Manolescu A, et al. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet. 2007;39(5):631-637. (Pubitemid 46676102)
2. Yeager M, Orr N, Hayes RB, et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet. 2007;39(5):645-649. (Pubitemid 46676108)
3. Thomas G, Jacobs KB, Yeager M, et al. Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet. 2008;40(3):310-315. (Pubitemid 351311773)
4. Eeles RA, Kote-Jarai Z, Al Olama AA, et al. Identification of seven new prostate cancer susceptibility loci through a genomewide association study. Nat Genet. 2009;41(10):1116-1121.
5. Stadler ZK, Vijai J, Thom P, et al. Genome-wide association studies of cancer predisposition. Hematol Oncol Clin North Am. 2010;24(5):973-996.
6. Duggan D, Zheng SL, Knowlton M, et al. Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J Natl Cancer Inst. 2007;99(24):1836-1844. (Pubitemid 351767196)
7. Varghese JS, Easton DF. Genome-wide association studies in common cancers-what have we learnt? Curr Opin Genet Dev. 2010;20(3):201-209.
8. Xu Z, Bensen JT, Smith GJ, et al. GWAS SNP replication among African American and European American men in the North Carolina-Louisiana Prostate Cancer Project (PCaP). Prostate. 2011;71(8):881-891.
9. Waters KM, Le Marchand L, Kolonel LN, et al. Generalizability of associations from prostate cancer genome-wide association studies in multiple populations. Cancer Epidemiol Biomarkers Prev. 2009;18(4):1285-1289.
10. Haiman CA, Chen GK, Blot WJ, et al. Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans. PLoS Genet. 2011;7(5):e1001387. (doi:10.1371/ journal.pgen.1001387).
11. Takata R, Akamatsu S, KuboM, et al. Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population. Nat Genet. 2010;42(9):751-754.
12. Kim ST, Cheng Y, Hsu FC, et al. Prostate cancer risk-associated variants reported from genome-wide association studies: metaanalysis and their contribution to genetic variation. Prostate. 2010;70(16):1729-1738.
13. Liu H, Wang B, Han C. Meta-analysis of genome-wide and replication association studies on prostate cancer. Prostate. 2011;71(2):209-224.
14. Lai J, Kedda MA, Hinze K, et al. PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility. Carcinogenesis. 2007; 28(5):1032-1039. (Pubitemid 47072187)
15. Baade PD, Aitken JF, Ferguson M, et al. Diagnostic and treatment pathways for men with prostate cancer in Queensland: investigating spatial and demographic inequalities. BMC Cancer. 2010;10:452. (doi:10.1186/1471-2407/10/ 452).
16. Batra J, Tan OL, O'Mara T, et al. Kallikrein-related peptidase 10 (KLK10) expression and single nucleotide polymorphisms in ovarian cancer survival. Int J Gynecol Cancer. 2010;20(4): 529-536.
17. Taylor BS, Schultz N, Hieronymus H, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell. 2010; 18(1):11-22.
18. Denham JW, Bender R, Paradice WE. It's time to depolarise the unhelpful PSA-testing debate and put into practice lessons from the two major international screening trials. Med J Aust. 2010;192(7):393-396.
19. Ribas G, Milne RL, Gonzalez-Neira A, et al. Haplotype patterns in cancer-related genes with long-range linkage disequilibrium: no evidence of association with breast cancer or positive selection. Eur J Hum Genet. 2008;16(2):252-260.
20. Rafnar T, Sulem P, Stacey SN, et al. Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet. 2009;41(2):221-227.
21. Gudmundsson J, Besenbacher S, Sulem P, et al. Genetic correction of PSA values using sequence variants associated with PSA levels. Sci Transl Med. 2010;2(62):62ra92. (doi:10.1126/ scitranslmed.3001513).